posted on 2021-05-14, 10:00authored byGuy Decante, João B. Costa, Joana Silva-Correia, Maurice N. Collins, Rui L. Reis, Miguel J. Oliveira
In recent years, three-dimensional (3D) bioprinting has attracted wide research interest in biomedical engineering and clinical applications. This technology allows for unparalleled architecture control, adaptability and repeatability that can overcome the limits of conventional biofabrication techniques. Along with the emergence of a variety of 3D bioprinting methods, bioinks have also come a long way. From their first developments to support bioprinting requirements, they are now engineered to specific injury sites requirements to mimic native tissue characteristics and to support biofunctionality. Current strategies involve the use of bioinks loaded with cells and biomolecules of interest, without altering their functions, to deliver in situ the elements required to enhance healing/regeneration. The current research and trends in bioink development for 3D bioprinting purposes is overviewed herein.
Funding
Susceptibility of fish stocks to VHS, IHN and SVC viruses .FC1113
peer-reviewed
The full text of this article will not be available in ULIR until the embargo expires on the 08/04/2022
Other Funding information
Portuguese Foundation for Science and Technology, Fundo Europeu de Desenvolvimento Regional (FEDER)
Rights
This is the Accepted Manuscript version of an article accepted for publication in Biofabrication. IOP Publishing Ltd is not responsible for any errors or omissions in this version of the manuscript or any version derived from it. The Version of Record is available online at https://doi.org/10.1088/1758-5090/abec2c